Recently, the CSIC Population Department published the results of a study outlining the possible future evolution. According to the figures compiled by the INE in 2018, included in the study, in our country, there are 8,908,151 people over 65 years of age.
Which represents 19.1% of the population. Taking into account the low birth rate, the INE projects that in 2068 there will be more than 14 million people over 65 in our country, which represents 29.4% of the population.
Based on this prediction based on socio-statistical data, in our country and in the most technologically advanced European countries, which are also ageing at high speed.
It is very possible that the impact of AI has less to do with making autonomous cars possible or assistant robots, capable of recognizing our voice, and more with their ability to accelerate scientific-medical research to discover drugs that improve the quality of life of older people, or with the possibility of creating systems capable of performing surgical interventions remote with maximum precision.
Much More Data And Limited Amount Of Time
When talking about digital transformation and its advantages, on many occasions we focus on highlighting those that will lead to improving the efficiency of production, industrial and commercial processes.
But there is an area in which technologies such as machine learning and Artificial Intelligence can trigger relevant changes for future generations in the fields of science and health research.
At the most prestigious Biomedical Research Institutes, scientists know that finding new drugs is a complex, time-consuming process.
In addition to this difficulty, the amount of data available on the molecules and their properties is increasingly overwhelming, which makes it more difficult to obtain short-term results derived from new combinations.
Research is saturated with data and, as in other sectors, the time available to research in the scientific field is determined by criteria of profitability. Finding new medicines is also expensive and the entities that finance laboratories and institutes do not want to wait 20 years to extract benefits from their investment. The terms are shortened to a maximum of five years.
Artificial intelligence: A Key Ally In Medical Field
In this context, the computational and computational capabilities that AI offers to identify possibilities of combining between molecules, in a sea of data of astronomical dimensions, is a key and invaluable aid for researchers. Deep learning, or deep learning, helps to increase the chances of success of more complex pharmaceutical research, and may even open new avenues of exploration not contemplated.
The possibilities are many and everything points to the fact that increasing the quality of life of a large number of people in the United States will depend on its development in the coming decades.
AI, in addition to streamlining diagnostic processes through data analysis, allows better monitoring of patient needs, enables monitoring of follow-up of prescribed medication guidelines, opens the possibility of receiving personalized attention and gives rise to the Creating systems capable of helping physicians perform surgical procedures remotely can also become the most valuable tool for advancing the research that we have known in the last half-century.
